23andMe To Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services. Bankruptcies, Mergers, Acquisitions and Divestitures, Genetics and Heredity, Privacy, 23andMe, Regeneron Pharmaceuticals Inc, Bonta, Rob (1972- ), Wojcicki, Anne, Yancopoulos, George D, Tarrytown (NY), DNA (Deoxyribonucleic Acid) Read More

Leave a Comment

Your email address will not be published. Required fields are marked *